TGA fines COVID-19 fast antigen testing provider more than $ 100,000

Written by Javed Iqbal

The Therapeutic Goods Administration said it has issued eight infringement notices to Hough Pharma Pty Ltd.

The TGA said the fines were issued for “alleged failure to provide information” to the government body to “demonstrate the safety and performance of three COVID-19 rapid antigen tests”.

Generic rapid antigen test
A supplier of COVID-19 rapid antigen tests has been hit by several fines totaling $ 106,560. (Ask Macheda / file)

“All sponsors of medical devices approved by the TGA are required by the Therapeutic Goods Act 1989 to provide this evidence to the TGA when requested and within the specified time frame,” the TGA said in a statement.

“This helps ensure that medical devices are safe and function appropriately for their intended purpose.”

The government also claimed that “lack of customer support has been reported by consumers and verified by TGA surveys”.

However, Hough told Pharma’s CEO, Jackson Hough Sydney Morning Herald and Aging the company had consistently provided data to the regulator.

“Although Pharma has constantly provided efficacy, safety and variants data to TGA to demonstrate that our products effectively detect COVID-19 and its variants,” he said. the newspapers.

Hough also added that the company denied allegations of lack of customer service.

“We operate a 1800 number, in addition to email and SMS response options, offered from 7 a.m. to 9 p.m., seven days a week,” he said in a statement to the newspapers.

Nine.com.au has contacted Hough Pharma and TGA for comments.

About the author

Javed Iqbal

Leave a Comment